Retatrutide
Triple agonist (GIP/GLP-1/glucagon) — next-generation metabolic therapy.
Why Retatrutide.
Triple receptor agonism
Significant metabolic rate increase via glucagon action
Clinical trial weight loss exceeding 20%
Weekly subcutaneous injection
About Retatrutide.
Retatrutide is a triple incretin receptor agonist targeting GIP, GLP-1, and glucagon receptors. Clinical trials have shown profound weight reduction effects, making it one of the most potent investigational metabolic agents currently available through specialized telehealth providers.
How it works.
From intake to your first dose — four straightforward steps.
Complete intake
A brief health questionnaire reviewed by our clinical team. Takes about 5 minutes.
Provider review
A board-certified clinician reviews your history within 48 hours.
Compounded & shipped
Your prescription is compounded in a licensed US pharmacy and shipped to your door.
Ongoing support
Telehealth follow-up to adjust your protocol as needed.
Ready to start Retatrutide?
Complete a brief health intake and a licensed provider will review your request within 48 hours. No commitments.
All prescriptions are issued at the sole discretion of licensed providers. Protocol Health Rx does not guarantee prescription approval.